Engen BIO
Redwood City, US · Founded 2016 · Delaware LLC
Founders & leadership
MA
Mark AlfenitoManager
AM
Adam M GuttmannManager
Reported raises · per SEC filings
Form D private placements$632K disclosed across 1 round · 2020
▶$632KraisedJan 2020 · 8 investors · BiotechnologyRule 506(b)
▶$632KraisedJan 2020 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Adam M GuttmannDirector
- Mark AlfenitoExecutive Officer, Director
- Offering amount
- $632K
- Amount sold
- $632K
- Minimum investment
- $25K
- Sales commissions
- $15K
- Proceeds to insiders
- $30K
- Placement agents
- TRANCEKA CAPITAL, LLC
- First sale
- Jan 2020
- Incorporated
- Limited Liability Company, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Engen BIO raised?
- Engen BIO has disclosed $632K raised across 1 round.
- Where is Engen BIO headquartered?
- Engen BIO is headquartered in Redwood City, US.